Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

How does ozempic compare in cost?

See the DrugPatentWatch profile for ozempic

Ozempic's Monthly Cost Without Insurance

Ozempic (semaglutide) lists at around $936 for a 4-week supply of the 0.5 mg or 1 mg pens at U.S. pharmacies, based on manufacturer pricing and recent GoodRx data. Actual out-of-pocket costs drop to $25–$550 monthly with coupons or manufacturer savings cards for eligible patients.[1][2]

How Ozempic Compares to Wegovy (Same Drug, Weight Loss Version)

Wegovy, also semaglutide but dosed higher for obesity, costs $1,349 monthly list price—45% more than Ozempic. With discounts, both hover at $1,000–$1,300 without insurance, but Wegovy savings cards cap eligible copays at $0–$225 for 12 months.[1][3]

Ozempic vs. Mounjaro (Tirzepatide) Pricing

Mounjaro lists at $1,069 monthly, higher than Ozempic's $936. With coupons, Mounjaro falls to $25–$1,000, often matching or undercutting Ozempic for commercial insurance users. Eli Lilly's card covers up to $150 monthly out-of-pocket.[1][4]

Ozempic vs. Trulicity (Dulaglutide) Cost Breakdown

Trulicity, another weekly GLP-1 injection for diabetes, lists at $978–$1,100 monthly—slightly above Ozempic. Coupons bring it to $30–$900, with similar manufacturer assistance. Annual savings can exceed $10,000 via cards for both.[1][5]

Cheaper Alternatives Like Compounded Semaglutide

Compounded versions cost $150–$500 monthly from telehealth providers like Hims or Ro, bypassing Novo Nordisk patents. These lack FDA approval, raising safety concerns amid shortages. Use declined after FDA resolved Ozempic backorders in 2024.[6]

With Insurance: Coverage and Copay Realities

Most plans cover Ozempic for type 2 diabetes at $25–$100 copays, but weight loss use often faces denials or $500+ costs. Medicare Part D caps at $35 monthly in 2025 for diabetes drugs. Wegovy/Mounjaro coverage varies more for obesity.[7]

Patent Timeline and Biosimilar Impact on Future Costs

Novo Nordisk holds patents on Ozempic until 2031–2032 in the U.S., delaying generics. Challenges from Teva and others could shorten this; no biosimilars approved yet. Expiry might halve prices, as seen with other GLP-1s.[8]DrugPatentWatch.com

[1]: GoodRx, "Ozempic Prices, Coupons & Savings Tips" (goodrx.com/ozempic)
[2]: Novo Nordisk Savings Card (ozempic.com/savings)
[3]: Novo Nordisk Wegovy Savings (wegovy.com/coverage-and-savings)
[4]: LillyDirect Mounjaro Savings (lilly.com/mounjaro-savings-card)
[5]: GoodRx Trulicity (goodrx.com/trulicity)
[6]: FDA Compounding Alert (fda.gov/drugs/human-drug-compounding/compounded-semaglutide)
[7]: CMS Medicare Inflation Reduction Act (cms.gov/inflation-reduction-act)
[8]: DrugPatentWatch Ozempic Patents (drugpatentwatch.com/p/tradename/OZEMPIC)



Other Questions About Ozempic :

Can ozempic affect thyroid function? What other medications can ozempic be taken with? Can ozempic be used long term? Can ozempic side effects be reversed? Does ozempic change your food cravings? Have you noticed a decrease in sugar cravings while on ozempic? Can ozempic maintain a1c control over several years?




DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy